ConductScience.org, home
Papers
API referenceFor AI assistants

Paper11368285

Achieving optimal outcomes in chronic lymphocytic leukaemia.

Hamblin TJ. Drugs, 2001. Cited by 16 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Achieving optimal outcomes in chronic lymphocytic leukaemia. Papers, record 11368285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11368285

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Achieving optimal outcomes in chronic lymphocytic leukaemia.
PubMed
Journal
Drugs
PubMed
Year
2001
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.45
iCite
Revised in PubMed
2026-10-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hamblin TJT J

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Leukemia, Lymphocytic, Chronic, B-CellMajor topic
Aged
Humans
Immunotherapy
Middle Aged
Prognosis
Randomized Controlled Trials as Topic

Source PubMed

References127

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
2890,666A clinical staging system for chronic lymphocytic leukemia: prognostic significance.Cancer1977https://conductscience.org/library/papers/890666PubMed
32,784,491Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.J Clin Oncol1989https://conductscience.org/library/papers/2784491PubMed
45,953,036X-radiation and alkylating agents as possible "trigger" mechanisms in the autoimmune complications of malignant lymphophroliferative disease.Clin Exp Immunol1966https://conductscience.org/library/papers/5953036PubMed
510,334,546Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia.J Clin Oncol1999https://conductscience.org/library/papers/10334546PubMed
69,885,918Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.Int Immunol1998https://conductscience.org/library/papers/9885918PubMed
710,319,383Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma.Semin Hematol1999https://conductscience.org/library/papers/10319383PubMed
88,943,862Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.Blood1996https://conductscience.org/library/papers/8943862PubMed
98,102,691Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia.Lancet1993https://conductscience.org/library/papers/8102691PubMed
107,612,497Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia.Ann Oncol1995https://conductscience.org/library/papers/7612497PubMed
119,698,219Severe autoimmune hemolytic anemia in eight patients treated with fludarabine.Hematol Cell Ther1998https://conductscience.org/library/papers/9698219PubMed
1210,355,587Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy.Ann Oncol1999https://conductscience.org/library/papers/10355587PubMed
1327,463,4952-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia.Leuk Lymphoma1991https://conductscience.org/library/papers/27463495PubMed
148,641,639Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.Haematologica1996https://conductscience.org/library/papers/8641639PubMed
1510,477,712Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.Blood1999https://conductscience.org/library/papers/10477712PubMed
168,547,072Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.Br J Haematol1995https://conductscience.org/library/papers/8547072PubMed
179,670,041CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.J Exp Med1998https://conductscience.org/library/papers/9670041PubMed
189,593,789Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.N Engl J Med1998https://conductscience.org/library/papers/9593789PubMed
194,693,581Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia.Cancer1973https://conductscience.org/library/papers/4693581PubMed
207,669,706Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.Ann Oncol1995https://conductscience.org/library/papers/7669706PubMed
219,482,528Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goals.Semin Oncol1998https://conductscience.org/library/papers/9482528PubMed

See all 127 references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
25,586,345Different frequencies and effects of ABCB1 T3435C polymorphism on clinical and laboratory features of B cell chronic lymphocytic leukemia in Kurdish patients.Tumour Biol2015https://conductscience.org/library/papers/25586345PubMed
21,534,866Quality of life domains among non-Hodgkin lymphoma survivors: an integrative literature review.Leuk Lymphoma2011https://conductscience.org/library/papers/21534866PubMed
14,524,733Oral fludarabine.Drugs2003https://conductscience.org/library/papers/14524733PubMed

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD5921PubTator's text mininghttps://conductscience.org/library/genes/921NCBI Gene
CD521,043PubTator's text mininghttps://conductscience.org/library/genes/1043NCBI Gene
CD79B974PubTator's text mininghttps://conductscience.org/library/genes/974NCBI Gene
FCER22,208PubTator's text mininghttps://conductscience.org/library/genes/2208NCBI Gene
KRT2054,474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11368285

GET https://conductscience.org/api/papers/v1/11368285/references?page=2

API referenceFor AI assistants